HRS 2022 – Mapping and Ablation EP Booth Agenda | Abbott
CARDIOVASCULAR
hamburger
HRS 2022

EP Booth Agenda

1:30 – 1:45 pm PT
Abbott Booth

Leveraging New Remote Support Workflows with EnSite™ X EP System

Dale Yoo, MD
Electrophysiologist, Heart Rhythm Specialist, PLLC
Dale Yoo, MD
3:05 – 3:20 pm PT
Abbott Booth

STaMP Mapping and EnSite™ Omnipolar Technology in the Left Atrium: New Approaches in Persistent AF Ablation

Christopher Woods, MD, PH.D, FHRS
Director of Cardiac Electrophysiology, Sutter Health
Christopher Woods, MD
2:00 – 2:15 pm PT
Abbott Booth

Persistent AF Mapping Workflows with EnSite™ Omnipolar Technology and EnSite™ X EP System

Dr. Pasquale Santangeli
Associate Professor of Medicine at the Hospital of the University of Pennsylvania
Pasquale Santangeli, MD
2:50 – 3:05 pm PT
Abbott Booth

EnSite™ Omnipolar Technology and Imaging for VT: Best Practices in Substrate Detection and Activation Mapping​

Dr. Ivo Roca
Electrophysiologist, Hospital Clinic of Barcelona
Ivo Roca, MD
10:05 – 10:20 am PT
Abbott Booth

Refining Low Fluoro Workflows with EnSite™ X EP System​

Mansour Razminia, MD
Electrophysiologist, AMITA Health Medical Group Heart & Vascular Elgin
Mansour Razminia, MD
1:30 – 1:45 pm PT
Abbott Booth

Highlights from the Persist-END Clinical Trial

Monica Lo, MD
Electrophysiologist, Arkansas Heart Hospital
Monica Lo, MD

MAT-2203706 v2.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.